A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation.

Details

Language :

English

ISSN :

15257304

Volume :

19

Issue :

5

Database :

Complementary Index

Journal :

Clinical Lung Cancer

Publication Type :

Academic Journal

Accession number :

131442316

Full Text :

https://doi.org/10.1016/j.cllc.2018.03.016